Evidence map›Paper›PMID 34327118›Full record

ArticleAnnals of global health2021

The Dual/Global Value of SARS-CoV-2 Genome Surveillance on Migrants Arriving to Europe via the Mediterranean Routes.

Claudia Marotta, Paola Stefanelli, Fabio Tramuto, Ulrico Angeloni, Carmelo Massimo Maida, Achille Cernigliaro, Teresa Barone, Francesco Vitale, Giovanni Rezza, Walter Mazzucco and 1 more

Open access · goldAbstract read
In one paragraph

Article in Annals of global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Claudia MarottaGeneral Directorate of Health Prevention, Ministry of Health, Rome, Italy.ORCID 0000-0003-4199-9060
Paola StefanelliDepartment of Infectious Diseases, National Institute of Health (ISS), Italy.
Fabio TramutoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, Italy.ORCID 0000-0003-0108-4608
Ulrico AngeloniGeneral Directorate of Health Prevention, Ministry of Health, Rome, Italy.
Carmelo Massimo MaidaDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, Italy.ORCID 0000-0002-6989-9259
Achille CernigliaroRegional Health Authority of Sicily, Palermo, Italy.
Teresa BaroneDepartment of Laboratory Diagnostics, Local Health Unit of Palermo, Palermo, Italy.
Francesco VitaleDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, Italy.
Giovanni RezzaGeneral Directorate of Health Prevention, Ministry of Health, Rome, Italy.
Walter MazzuccoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties "G. D'Alessandro", University of Palermo, Italy.ORCID 0000-0001-5090-1366
Sami-Surv Collaboration
Ministero della Salute · ITAzienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo · ITUniversity of Palermo · ITNational Institute of Infectious Diseases · JPRegional Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the pandemic, 34,154 migrants, refugees or asylum-seekers landed in Sicily (Italy) in 2020, representing the main point of entry by sea into Europe. The SARS-CoV-2 surveillance program among migrants arriving to Sicily via the Mediterranean Sea, made by the combination of clinical examination and molecular testing, has been integrated by full-genome sequencing strains using the NGS technology from the last week of February. To date, more than one hundred full-genome strains have been sequenced and 8 different lineages have been identified mostly belonging to the lineages B.1.1.7 and B.1.525. As global access to COVID-19 vaccines should be ensured, the need to provide more detailed information to inform policies and to drive the possible re-engineering of vaccines needed to deal with the challenge of new and future variants should be highlighted.

Indexed as

COVID-19Genome, ViralSARS-CoV-2COVID-19 VaccinesHumansMolecular Diagnostic TechniquesSicilyTransients and MigrantsCOVID-19 Vaccines

Identifiers

PMID34327118
PMCPMC8300587
OpenAlexW3185977259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.